| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 05/10/2005 | US6890914 Method of locking 1α-OH of vitamin D compounds in axial orientation |
| 05/06/2005 | WO2005040357A2 Compounds and methods for fluorescent labeling |
| 05/06/2005 | WO2005040163A1 Heterocyclic compounds that block the effects of advanced glycation end products (age) |
| 05/06/2005 | WO2004092116A8 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 05/06/2005 | WO2004002939A3 Aminoalcohol derivatives |
| 05/05/2005 | US20050096467 Blue 3H-naphtho[2,1-b]pyran compounds and use thereof in photochromic articles |
| 05/05/2005 | US20050096381 Derivatives of isoflavones |
| 05/05/2005 | US20050096380 For therapy of diabetes |
| 05/05/2005 | US20050096379 Sulfonamide cannabinoid agonists and antagonists |
| 05/05/2005 | US20050096340 lipophilic derivatives of paclitaxel, camptothecin, docetaxel or derivatives thereof; tocopherol succinate paclitaxel for example; emulsions for drug delivery, treating cancer; increased plasma elimination half-life compared to the parent therapeutic drug |
| 05/05/2005 | US20050096312 Antiserotonine agents; antidepressants; eating disorders; anxiolytic agents; sleep disorders; gastrointestinal disorders; cardiovascular disorders; muscular disorders; endocrine system diseases; muscular disorders; psychological disorders |
| 05/05/2005 | US20050095332 Extraction of phenolic antioxidants |
| 05/05/2005 | US20050092972 Photochromic compounds, useful, for example, in the manufacture of ophthalmic lenses, optical devices and window panes |
| 05/04/2005 | EP1528058A1 Polymorphic crystalline forms of celecoxib |
| 05/04/2005 | EP1446399B1 Piperazine derivatives having sst1 antagonistic activity |
| 05/04/2005 | EP1159254B1 Oxyalkylene-substituted aminophenol intermediate |
| 05/04/2005 | EP0792468B2 Novel photochromic indeno-fused naphthopyrans |
| 05/04/2005 | CN1611498A Grosvenor momordical flavone and its preparing prcess |
| 05/04/2005 | CN1611497A Anti-AIDS virus active substance desmosdumotin D and desmosdumotin and its analogue |
| 05/04/2005 | CN1199966C Process for preparing VE-succinate |
| 05/04/2005 | CN1199965C Method for separating catechin compound from theopolyphenols |
| 05/04/2005 | CN1199964C Soya aglycone-3'-sodium sulfonate and its preparing method and medicinal use |
| 05/04/2005 | CN1199963C Coumarin derivatives with COMT inhibiting activity |
| 05/03/2005 | US6888033 Contacting picornavirus with 2,6-dihydroxy acetophenone or its salt to inhibit replication of picornavirus |
| 05/03/2005 | US6888008 Process for preparing 3-isochromanone |
| 05/03/2005 | US6887896 7-[(7-Alkoxy)-chrom-3-en-6-yl]-heptatrienoic acid and 7-[(3-alkoxy)-5,6-dihydronaphthalen-2-yl]-heptatrienoic acid derivatives having serum glucose reducing activity |
| 05/03/2005 | US6887895 Aminolyzing; alcoholysis; comprises acid catalysts; for treatment of tumors or inhibition of fungi |
| 05/03/2005 | US6887883 Combating angiogenic activity in a human comprising administering to a chrysanthone compound |
| 05/03/2005 | US6887533 Dielectric anisotropy, photostable, heat resistance, high voltage holding, inexpensive manufacturing |
| 05/03/2005 | CA2149886C Process for preparing tetrazolyl-benzopyranones |
| 04/28/2005 | WO2005037830A1 Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands |
| 04/28/2005 | WO2005037817A2 Method for producing chromane derivatives that are devoid of enantiomers and are substituted in position 2 |
| 04/28/2005 | WO2005037816A1 Use of 8-prenylnaringenin for hormone replacement therapy |
| 04/28/2005 | WO2005037815A1 A manufacturing process of isoflavan or isoflavene derivatives |
| 04/28/2005 | WO2005037780A2 Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromium-6-yl-derivatives and drugs containing said compounds |
| 04/28/2005 | WO2005010160A3 Liquid crystals with reduced toxicity and applications thereof |
| 04/28/2005 | WO2004065539A3 Androgen receptor antagonists |
| 04/28/2005 | US20050090526 3-Cyano-7-methoxy-4-(3-bromo-4,5-dimethoxyphenyl)-2-oxo-2H-chromene; 7-Amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-2-imino-2H-chromene; anticancer, antitumor agent |
| 04/28/2005 | US20050090431 Water soluble prodrugs of hindered alcohols |
| 04/27/2005 | EP1525883A1 Ciclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 04/27/2005 | EP1525181A1 Process for the preparation of phenylalanine enamide derivatives |
| 04/27/2005 | EP1525177A1 Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof |
| 04/27/2005 | EP1524974A2 Transcription factor modulating compounds and methods of use thereof |
| 04/27/2005 | EP1214310B1 Novel photochromic naphthopyrans |
| 04/27/2005 | EP1011651B1 Method of treating diabetes and related disease states |
| 04/27/2005 | EP0968181B1 Perfluorynated sulphone salts, and their uses as ionic conduction materials |
| 04/27/2005 | CN1610684A Novel multi-ring organic compounds for regulating gut motility and food intake |
| 04/27/2005 | CN1610671A Quinoline compounds with 5-HT-antagonistic properties for therapy |
| 04/27/2005 | CN1610659A Carboxylic acid derivative |
| 04/27/2005 | CN1610542A New use for the treatment of gastroesophageal reflux disease |
| 04/27/2005 | CN1609086A MPTP affinity labels |
| 04/27/2005 | CN1198834C Water soluble produgs of hindered alcohols or phenols |
| 04/27/2005 | CN1198814C Salt |
| 04/27/2005 | CN1198614C Method for treating inflammatory diseases using pADPRT inhibitors |
| 04/21/2005 | WO2005035519A1 Method for producing 1-hydroperoxy-16-oxabicyclo[10.4.0]hexadecane |
| 04/21/2005 | WO2005035518A1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics |
| 04/21/2005 | WO2005035517A1 (3r, 4r)-trans-3,4-diarylchroman derivatives with estrogenic activity |
| 04/21/2005 | WO2005035491A2 PROCESS FOR SYNTHESIZING d-TOCOTRIENOLS FROM 2- VINYLCHROMANE COMPOUND |
| 04/21/2005 | WO2005035490A2 PROCESS FOR SYNTHESIZING d-TOCOTRIENOLS |
| 04/21/2005 | WO2005034960A1 Treatment of diseases associated with the egr-1 enhancer element |
| 04/21/2005 | WO2004062601A3 Antibacterial agents |
| 04/21/2005 | WO2004029028A3 9-cyano-substituted perylene-3,4-dicarboxylic acid monoimides as dyestuffs |
| 04/21/2005 | US20050085664 Process for producing chromone compound |
| 04/21/2005 | US20050085536 Peroxidation in diluent and presence of strong acid and neutralization in base, using perfluoro acids |
| 04/21/2005 | US20050085532 Prevention, therapy of central nervous system disorders ; antidepressants; anxiolytic agents; eating and sleep disorders; Alzheimer's disease; strokes; schizophrenia; incontinence; gastrointestinal disorders; cardiovascular disorders |
| 04/21/2005 | US20050085471 Using 2-morpholinyl-4H-pyrido(1,2-a)pyrimidin-4-one; enzyme inhibitors; antithrombotic agents ; restenosis; atherosclerosis; antihistamines; chronic obsessive pulminary disease; autoimmune diseases; anticancer agents; antiinflammatory agents |
| 04/21/2005 | US20050085466 such as 1-[4-(2-oxo-4-trifluoromethyl-1,2-dihydroquinolin-6-ylmethyl)benzenesulfonyl]-piperidine-3-carboxylic acid ethyl ester; for treatment of acne, alopecia, and oily skin; kits |
| 04/21/2005 | US20050085457 Therapeutic quinolone compounds with 5-ht-antagonistic properties |
| 04/21/2005 | US20050085431 Treatment of hypertension |
| 04/21/2005 | US20050084870 4,7-dichlorofluorescein dyes as molecular probes |
| 04/21/2005 | US20050084763 low melting electrolyte comprising salts where the anionic charge is delocalized, mixed with metallic salts, polar polymers and/or aprotic solvents |
| 04/21/2005 | CA2541590A1 Treatment of diseases associated with the egr-1 enhancer element |
| 04/21/2005 | CA2539878A1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics |
| 04/21/2005 | CA2539502A1 (3r,4r)-trans-3,4-diarylchroman derivatives with estrogenic activity |
| 04/20/2005 | EP1524270A1 Sulfur-containing proanthocyanidin oligomer composition and process for producing the same |
| 04/20/2005 | EP1524269A1 Use of 8-Prenylnaringenin for hormone replacement therapy |
| 04/20/2005 | EP1523478A2 Manufacture of isoflavones |
| 04/20/2005 | EP0880514B1 Non-steroidal polycyclic ring sulphamate derivatives, their preparation and their use as oestrone sulphatase inhibitors |
| 04/20/2005 | CN1608054A Therapeutic quinolone compounds with 5-HT-antagonistic properties |
| 04/20/2005 | CN1608050A Piperazine derivative |
| 04/20/2005 | CN1197857C Method for extracting tea polyhenols and tea pigment |
| 04/19/2005 | US6881753 Potassium channel inhibitors and method |
| 04/14/2005 | WO2005033288A2 Hedgehog pathway antagonists |
| 04/14/2005 | WO2005033093A1 7,8-bicycloalkyl-chroman derivatives |
| 04/14/2005 | WO2005033092A1 Chroman derivatives |
| 04/14/2005 | WO2005033091A1 Production of a-tocopherol from raw material not containing a-tocopherols |
| 04/14/2005 | WO2005033053A1 Process for producing product containing proanthocyanidin in high proportion |
| 04/14/2005 | WO2005032559A1 Nitric oxide donating derivatives for the treatment of cardiovascular disorders |
| 04/14/2005 | WO2005032542A1 Neutralizing agent for cavitating toxin |
| 04/14/2005 | WO2005032485A2 Compounds and methods for the treatment of attention-deficit hyperactivity disorder |
| 04/14/2005 | US20050080141 Amino diols useful in the treatment of alzheimer's disease |
| 04/14/2005 | US20050080119 Diaminopropionic acid derivatives |
| 04/14/2005 | US20050080073 Sulfonylaminocarboxiylic acid N-arylamides as guanylate cyclase activators |
| 04/14/2005 | US20050080024 Can safely and effectively lower blood cholesterol while simultaneously decreasing endothelial dysfunction and decreasing vascular oxidative stress |
| 04/14/2005 | US20050079487 Liquid crystals with reduced toxicity and applications thereof |
| 04/14/2005 | US20050079136 Therapy for pain, appetite inttensifiers, multiple sclerosis and asthma; drug delivery |
| 04/14/2005 | US20050077169 Column packed with particles having a multiplicity of nanometer-order pores is used for flowing a reaction solution through; activating the reaction with laser light irradiating, infrared, x-rays, gamma -rays, or microwave pulses |
| 04/14/2005 | CA2545479A1 Compounds comprising a nitric oxide moiety for inducing expression of apoa1 for the treatment of cardiovascular disorders |
| 04/14/2005 | CA2539724A1 Process for producing product containing proanthocyanidin in high proportion |
| 04/13/2005 | EP1522313A1 Combination therapy of radiation and valdecoxib for the treatment of neoplasia |